Xu et al reported a nomogram for predicting survival for a patient with an unresectable hepatocellular carcinoma who undergoes transcatheter arterial chemoembolization (TACE). This can help to identify a patient who may or may not benefit from the procedure. The authors are from Sun Yat-sen University, State Key Laboratory of Oncology in South China, The First Affiliated Hospital, The Chinese University of Hong Kong and Prince of Wales Hospital.